Efficacy of infliximab in refractory Beh&ccedil;et&rsquo;s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients | Zendy

Fabrizio Cantini | Zendy; Niccoli Laura | Zendy; Nannini Carlotta | Zendy; Kaloudi Olga | Zendy; CassarÃ Emanuele | Zendy; Susini Massimo | Zendy; Lenzetti Ivo | Zendy

Open Access

Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

Author(s) -

Fabrizio Cantini,

Niccoli Laura,

Nannini Carlotta,

Kaloudi Olga,

CassarÃ Emanuele,

Susini Massimo,

Lenzetti Ivo

Publication year - 2011

Publication title -

biologics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.948

H-Index - 38

eISSN - 1177-5491

pISSN - 1177-5475

DOI - 10.2147/btt.s27343

Subject(s) - medicine , infliximab , behcet's disease , adverse effect , refractory (planetary science) , prospective cohort study , uveitis , prednisone , surgery , macular edema , visual acuity , gastroenterology , ophthalmology , disease , physics , astrobiology

To evaluate the long-term efficacy of infliximab in patients with refractory Behçet's disease (BD)-associated and idiopathic posterior uveitis (PU).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research